MACS SOFTWARE LIMITED

Financial Health Score: D+

Explanation: The patient is in a critical but stabilising condition. MACS Software Limited suffers from severe balance sheet insolvency (negative net assets), meaning its liabilities far exceed its assets. However, unlike previous years where the business was bleeding cash, the latest results show a significant return to profitability and improved cash reserves. This turnaround appears to be the result of radical "surgery"—reducing the workforce to zero and restructuring operations. While the vital signs are improving, the underlying structural weaknesses (technical insolvency) remain life-threatening to the business if not addressed.

1. Key Vital Signs

• Net Assets (Equity): -£248,047
  • Interpretation: This is a symptom of chronic insolvency. The company's liabilities outweigh its assets by over a quarter of a million pounds. Historically, this hole was much deeper (£-374,723 in 2024), indicating that the patient is recovering, but the accumulated deficit from past years still weighs heavily on its financial health.
• Profitability: +£126,676
  • Interpretation: A strong, healthy pulse. After years of accumulating losses, the company generated a significant profit in the 2025 financial year. This is the most positive vital sign, proving the business model can generate wealth, albeit after severe cost-cutting.
• Cash at Bank: £68,812
  • Interpretation: Improved hydration. Cash levels have doubled from £34,599 in 2024 and are vastly improved from the near-zero levels seen in earlier years (e.g., £40 in 2021). This provides the necessary fluidity to keep operations moving in the short term.
• Current Ratio: 0.06 (Current Assets £16,104 / Current Liabilities £257,831)
  • Interpretation: Severe shortness of breath. The company has minimal current assets to cover its immediate liabilities. A healthy ratio is typically above 1.0. While cash is present, the overall short-term liquidity position is dangerously low.
• Employee Count: 0 (Down from 8 in 2024)
  • Interpretation: Radical surgery. The removal of all employees suggests the business has been restructured, likely outsourcing operations or relying on related corporate entities (like SovTech Ventures) to deliver services.

2. Symptoms Analysis

The "Deferred Revenue" Tumor The largest single liability is "Deferred Revenue" (UK SaaS + Foreign SaaS + Installation), totaling approximately £221,797. While this sits on the balance sheet as a liability (a symptom of owing services to customers), in the software industry, this is often a benign or even positive sign. It represents cash already received from clients for annual software subscriptions that the company has not yet "earned" in accounting terms. It is a "good" liability to have, as it represents guaranteed future income, but it currently makes the insolvency look worse than the operational reality.

The Related-Party Anomaly The Debtors (Current Assets) show a negative balance of (£52,708). This is caused by a "Loan Account - SovTech Venture" showing a credit balance of (£92,546). In simple terms, the company is listing an amount it owes to SovTech (a corporate director and related party) as a negative asset rather than a liability. This accounting presentation distorts the true picture of both assets and liabilities and suggests deep financial entanglement with the parent/related company.

3. Diagnosis

Chronic Insolvency with Acute Recovery Symptoms

The business is technically insolvent—liabilities exceed assets, and it cannot pay its current debts from current assets if all were called in immediately. However, the underlying operational health has dramatically improved. The "disease" of annual losses has been cured, replaced by a healthy profit of £126,676.

The structural change (moving from 8 employees to 0) suggests the company has transitioned from a standalone operating entity to a shell or holding company that likely licenses software through related entities. The financial health of this specific legal entity is now entirely dependent on the health and support of its related parties, specifically Nimos Limited and SovTech Ventures. If those entities withdraw support or call in their loans, the patient cannot survive independently.

4. Recommendations

1. Capital Transfusion: The directors must address the negative equity. This could be done by converting director/related party loans into equity, or injecting fresh share capital. This will shore up the balance sheet and remove the "technically insolvent" diagnosis.
2. Clarify Related-Party Positions: The negative debtor balance with SovTech Venture must be reclassified. Amounts owed to related parties should sit in creditors. Clearing up this accounting presentation will provide a more transparent view of the company's true liquidity.
3. Service Delivery Assurance: With £221k in deferred revenue and zero employees, the company must ensure it has the capacity (likely via contracts with SovTech) to deliver the software services it has already sold. Failure to deliver could lead to refund requests, which would instantly fatal to cash flow.
4. Monitor Cash Conversion: Continue to prioritize cash generation. The improvement from near-zero cash in 2021 to £68k in 2025 is excellent. Maintain this discipline to organically eliminate the accumulated deficit over the next few years.